In 2025, PharmaResearch conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Waste Generated | 193.09a | 204.03a | 169.11a | |
Total Waste Recovered | 178.5a | 182.42a | 153.13a | |
Total Hazardous Waste Generated | 193.46a | 203.77a | 168.94a | |
Non-Hazardous Waste Disposed | N/A | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, PharmaResearch generated a total of 193metric tonnes of waste.a
Of this amount, 92.44% of PharmaResearch's total waste generated was recovered through methods such as recycling, reuse, or composting, while 7.56% was disposed of through landfilling, incineration, or combustion.a
In 2025, PharmaResearch reported a total waste generation of 193 metric tonnes, of which 92.44% was recovered through recycling, reuse, or composting.This high recovery rate suggests that PharmaResearch has implemented strong circular economy practices and actively prioritizes sustainable waste management.a
Since 2023, PharmaResearch's total waste generation increased by 14.18%, but declined by 5.36% in the year 2025, suggesting a potential shift toward more efficient material use or the early impact of waste reduction strategies.a
Over the same period, PharmaResearch's waste recovery rate increased by 2.09%, including a 3.4% rise in 2025, indicating growing emphasis on circularity and improved operational practices for diverting waste from disposal.a
Overall, while PharmaResearch has increased waste over the long term, recent reductions in waste generation and strong improvements in recovery indicate a strategic pivot toward better waste management and more sustainable practices.